Clinical Case Presentation Scaffold

Template Overview

Medical education and clinical case conferences require rigorous diagnostic synthesis, systematic physical examination reporting, and evidence-based treatment rationale. The Clinical Case Presentation Scaffold structures complex inpatient and outpatient cases into an academic, HIPAA-aligned educational record in plain Markdown.

Markdown Template Structure

Copy the block below or click Download .md File to add this template directly to your personal vault:

---
title: "Clinical Case: [Diagnostic Challenge / Primary Finding]"
date: [YYYY-MM-DD]
presenter: "[[Medical Resident / Fellow Name]]"
attending_physician: "[[Attending Consultant Name]]"
clinical_service: "[[Internal Medicine / Neurology]]"
patient_demographics: "Anonymized: 54yo M / Educational Case"
hipaa_de_identified: true
tags: [medicine, clinical-case, grand-rounds, differential-diagnosis, education]
---

# Clinical Case Presentation — [Case Subject]

## 1. Patient History & Chief Complaint
- **Chief Complaint (CC):** Acute onset progressive bilateral lower extremity weakness over 48 hours.
- **History of Present Illness (HPI):** Detailed chronological progression of symptoms, antecedent viral infections, and associated neurologic deficits.
- **Past Medical & Surgical History:** Relevant historical co-morbidities and historical medications.

## 2. Physical Examination & Pertinent Objective Findings
| System Examined | Physical Findings Observed | Clinical Significance |
|---|---|---|
| **Vital Signs** | BP 128/78, HR 68, SpO2 99% on room air | Hemodynamically stable |
| **Neurologic: Motor** | Symmetric proximal weakness 3/5 lower, 4/5 upper | Ascending paralysis pattern |
| **Neurologic: Reflexes**| Absent patellar and Achilles deep tendon reflexes (0/4) | Areflexia characteristic |
| **Laboratory / CSF** | Lumbar puncture: Elevated protein (124 mg/dL), normal WBC | Albuminocytologic dissociation |

## 3. Structured Differential Diagnoses (Ranked)
1. **Guillain-Barré Syndrome (AIDP):** Highest clinical suspicion given ascending motor deficit, areflexia, and CSF protein-cytological findings.
2. **Acute Spinal Cord Compression:** Considered, but ruled out via normal emergent MRI of the total spine.
3. **Tick Paralysis / Myasthenia Gravis:** Excluded on absence of ocular symptoms and normal electrodiagnostic testing.

## 4. Evidence-Based Management & Teaching Pearls
- **Therapeutic Intervention:** Initiated Intravenous Immunoglobulin (IVIG) 0.4 g/kg/day for 5 days.
- **Monitoring Protocol:** Serial forced vital capacity (FVC) and negative inspiratory force (NIF) monitoring every 4 hours for diaphragmatic involvement.
- **Clinical Teaching Pearl:** Albuminocytologic dissociation in CSF may not manifest until the second week of symptom onset in up to 20% of GBS presentations.

Filled Real-World Example

Here is a realistic example demonstrating how this template captures actual deliberations:

---
title: "Clinical Case: Acute Ascending Paralysis"
date: 2026-10-10
presenter: "[[Dr. Sophia Chen]]"
attending_physician: "[[Dr. Robert Sterling]]"
clinical_service: "Inpatient Neurology"
patient_demographics: "Anonymized Educational Record"
hipaa_de_identified: true
tags: [medicine, clinical-case, grand-rounds, differential-diagnosis, education]
---

# Clinical Case Presentation — Acute Ascending Paralysis

## 1. Presentation
Dr. Chen presented a challenging diagnostic case of a 54-year-old presenting with symmetric weakness following Campylobacter enteritis.

## 2. Attending Discussion
Dr. Sterling reviewed the clinical indications for choosing IVIG over plasma exchange, noting equivalent therapeutic efficacy with reduced hemodynamic variability in dysautonomic patients.

## 3. Educational Outcome
Case documentation archived into clinical teaching library with verified full de-identification.

When to Use and When to Avoid

When to Use

• Use during clinical morning report, morbidity and mortality (M&M) conferences, and grand rounds.
• Use to structure differential diagnoses and evidence-based patient management rationale.
• Use to build a personal searchable medical reference repository in your local vault.

When to Avoid

• Avoid storing non-anonymized real patient identifiers without institutional HIPAA compliance review.
• Avoid for real-time electronic health record (EHR) chart documentation.

On-Device AI Integration

Summarize your recording in Oyma with this local instruction:

Summarize the clinical medical case presentation recording:
1. Outline the patient history, presenting physical exam findings, and objective laboratory results.
2. Group differential diagnoses discussed, detailing rationale for inclusion and exclusion.
3. Extract treatment plans initiated, monitoring parameters, and clinical teaching pearls shared.
Output in clean, structured Markdown.

Your data remains securely on your Mac with zero cloud exposure.